Tech Company Financing Transactions

Exogenesis Funding Round

On 12/31/2009, Exogenesis announced $323 thousand in funding from .

Transaction Overview

Company Name
Announced On
12/31/2009
Transaction Type
Venture Equity
Amount
$323,000
Round
Undisclosed
Investors

No investors have been recorded for this company.

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
20 Fortune Dr.
Billerica, MA 01821
USA
Email Address
Overview
Exogenesis is seeking partners in collaborative research and commercialization of its proprietary nanoscale surface modification technology.
Profile
Exogenesis LinkedIn Company Profile
Social Media
Exogenesis Company Twitter Account
Company News
Exogenesis News
Facebook
Exogenesis on Facebook
YouTube
Exogenesis on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Dmitry Shashkov
  Dmitry Shashkov LinkedIn Profile  Dmitry Shashkov Twitter Account  Dmitry Shashkov News  Dmitry Shashkov on Facebook
VP - Engineering
James Bachand
  James Bachand LinkedIn Profile  James Bachand Twitter Account  James Bachand News  James Bachand on Facebook
VP - Engineering
Allen Kirkpatrick
  Allen Kirkpatrick LinkedIn Profile  Allen Kirkpatrick Twitter Account  Allen Kirkpatrick News  Allen Kirkpatrick on Facebook
VP - Product Management
Michael Walsh
  Michael Walsh LinkedIn Profile  Michael Walsh Twitter Account  Michael Walsh News  Michael Walsh on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/31/2009: Core Solutions venture capital transaction
Next: 12/31/2009: Tolerogenics venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary